Trial Profile
A retrospective, observational study of dapagliflozin in patients with type-2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Dec 2016 Results assessing HbA1c,body weight and blood pressure published in the Diabetes Therapy (2016).
- 21 Mar 2016 New trial record